Dr. Rajendra Rohokale|Drug Discovery and Development| Best Researcher Award

Dr. Rajendra Rohokale| Drug Discovery and Development ,Best Researcher Award

Dr. Rajendra Rohokale at university of florida,United States

PROFILE  

Orcid

🎓Early Academic Pursuits :

Dr. Rajendra Shankarrao Rohokale embarked on his academic journey with a strong foundation in the sciences, earning his Bachelor of Science in Chemistry from New Arts, Science, and Commerce College, Ahmednagar, affiliated with Savitribai Phule Pune University, Pune, India. His academic pursuit continued with a Master of Science in Organic Chemistry from the same university, where he honed his skills in synthetic organic chemistry, laying the groundwork for his future research endeavors.

During his postgraduate studies, Dr. Rohokale demonstrated a profound interest in organic chemistry, particularly in the areas of synthetic carbohydrate chemistry and glycoscience. His early academic years were marked by a commitment to exploring the complexities of organic compounds, setting the stage for his later achievements in the field.

💼Professional Endeavors :

Dr. Rohokale’s professional journey is characterized by significant contributions to the field of synthetic organic chemistry, with a focus on carbohydrate chemistry, glycoscience, and photoredox catalysis. After completing his Ph.D. in Organic Chemistry from the Department of Chemistry, Savitribai Phule Pune University, he joined the University of Florida as a Research Assistant Professor. Under the mentorship of Prof. Zhongwu Guo, a prominent figure in carbohydrate chemistry, Dr. Rohokale’s work primarily involved the synthesis of complex carbohydrates and their conjugates for therapeutic applications.

Before his tenure at the University of Florida, Dr. Rohokale held a prestigious SERB National Post-doctoral Fellowship at the National Chemical Laboratory, Pune, where he worked under the guidance of Dr. C. V. Ramana. His research during this period focused on the applications of iridium-catalyzed reactions and photoredox catalysis in organic chemistry, contributing to the development of new methodologies in the field.

Dr. Rohokale’s professional experience also includes an international collaboration during the Indigo Program-2012, where he worked on visible light photoredox-catalysis with Prof. Burkhard Koenig at the University of Regensburg, Germany. This collaboration further enriched his research profile, leading to innovative contributions in organic synthesis.

🔬Contributions and Research Focus :

Dr. Rohokale has made significant contributions to the fields of synthetic organic chemistry, carbohydrate chemistry, and photoredox catalysis. His research primarily focuses on developing practical and efficient methods for the chemical and chemoenzymatic synthesis of complex oligosaccharides and glycoconjugates. These include glycoproteins and glycolipids, which are applied to studying related biological and medical problems, such as the functions of glycans and their relationships with diseases.

One of Dr. Rohokale’s notable research contributions is in the area of glycolipids synthesis. His work on glycosylated liposomes for targeted drug delivery and vaccination has potential applications in diagnosing and treating human diseases, including cancer and bacterial infections. His research also extends to the synthesis of biologically relevant molecules, such as GSLs, and their use as probes to explore disease mechanisms.

🏅Accolades and Recognition :

Dr. Rohokale’s academic and research excellence has been recognized through various awards and honors. He was selected for the prestigious SERB National Post-doctoral Fellowship in 2017, acknowledging his potential to contribute to scientific research in India. His selection as a Post-doctoral Fellow at the University of Florida in 2019 further underscores his expertise in carbohydrate chemistry and organic synthesis.

Additionally, Dr. Rohokale has been an active peer reviewer for several high-impact journals, including Chemical Communication and Organic Chemistry Frontiers, published by the Royal Society of Chemistry, and The Journal of Carbohydrate Chemistry, published by the American Chemical Society. His role as a reviewer highlights his standing in the scientific community and his commitment to advancing research in his field.

🌍Impact and Influence :

Dr. Rohokale’s research has had a profound impact on the field of synthetic organic chemistry, particularly in the areas of carbohydrate chemistry and photoredox catalysis. His work on the synthesis of complex carbohydrates and glycoconjugates has implications for medical science, particularly in understanding the role of glycans in diseases and developing new diagnostic tools and therapeutic approaches.

His innovative methodologies in organic synthesis have influenced researchers globally, contributing to the development of new strategies for synthesizing biologically relevant molecules. His collaboration with international institutions, including his work in Germany and the USA, has further extended his influence, making him a respected figure in his field.

🌟Legacy and Future Contributions :

As Dr. Rohokale continues his research at the University of Florida, his legacy in synthetic organic chemistry and carbohydrate research is expected to grow. His contributions to the development of new synthetic methods and their applications in medical science position him as a leading researcher with the potential to make groundbreaking discoveries in the future

🎓Publication 

Diastereoselective 1,3-dipolar intramolecular nitrone olefin cycloaddition (INOC) reaction of a sugar-derived allyl alcohol: Synthesis of functionalized aminocyclopentitols

  • Authors   :Rajendra Rohokale
  • Journal    :
    Carbohydrate Research
  • Year         :2024

Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes

  • Authors :Sayan Kundu; Rajendra Rohokale; Chuwei Lin; Sixue Chen; Shayak Biswas; Zhongwu Guo
    • Journal   :
      Journal of Lipid Research
    • Year       : 2024

Monophosphoryl Lipid A-Rhamnose Conjugates as a New Class of Vaccine Adjuvants

  •  Authors  :Rajendra Rohokale; Jiatong Guo; Zhongwu Guo
  • Journal    :
    Journal of Medicinal Chemistry

    Year         :  2024

Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines

  • Authors  :: Rajendra Rohokale; Zhongwu Guo
  • Journal   :
    ACS Infectious Diseases
  • Year        :   2023

Structural characterization and analysis of different epimers of neutral glycosphingolipid LcGg4 by ion mobility spectrometry-mass spectrometry

  • Authors  :Gao, T.; Lott, A.A.; Huang, F.; Rohokale, R.; Li, Q.; Olivos, H.J.; Chen, S.; Guo, Z.
  • Journal   :
    Analyst
  • Year        :  2022

Prof. Stefano Rivella|Hematology and Gene Therapy| Best Researcher Award

Prof. Stefano Rivella, Hematology and Gene Therapy ,Best Researcher Award

Prof. Stefano Rivella at Children’s Hospital of Philadelphia/University of Pennsylvania,United States

PROFILE  

Orcid

🎓 Early Academic Pursuits :

Stefano Rivella’s academic journey began in Italy, where he pursued his Bachelor of Science (BSc) and Doctor of Philosophy (PhD) at the University of Pavia. His dedication to the field of genetics was evident early on, as he received Italy’s Best University Thesis award from the Italian Genetics Institute (AGI) in 1991. Following his doctoral studies, Dr. Rivella remained at the University of Pavia as a Pre and Doctoral Trainee until 1997. His postdoctoral training took him to the prestigious Memorial Sloan Kettering Cancer Center, where he deepened his expertise in gene therapy and hematology.

🧬 Professional Endeavors :

Dr. Rivella’s professional career is marked by significant contributions to genetic medicine and pediatrics. He began his faculty appointments at Weill Cornell Medical College in 2002, where he served as an Assistant Professor of Genetic Medicine in Pediatrics. His innovative work in gene therapy and pediatrics led to his promotion to Associate Professor in both the Pediatrics and Graduate School divisions by 2008.

In 2015, Dr. Rivella transitioned to the Children’s Hospital of Philadelphia (CHOP), where he became a Professor of Pediatrics. His expertise and impact in the field were further recognized when he was appointed the Kwame Ohene-Frempong Endowed Chair in Pediatric Hematology later that year. Currently, he leads the RNA Gene Therapeutics group at The Penn Institute for RNA Innovation, a role he took on in 2023. This position underscores his leadership in pioneering RNA-based therapies for genetic disorders.

🔬 Contributions and Research Focus :

Dr. Rivella’s research has focused on gene therapy, particularly in the treatment of hemoglobinopathies such as thalassemia. His work has been instrumental in the development of innovative therapeutic strategies, including the approval of the clinical trial “ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia,” which is a significant milestone in the field. This trial, sponsored by the Children’s Hospital of Philadelphia, utilizes the ALS20 vector generated in Dr. Rivella’s laboratory, reflecting his deep involvement in cutting-edge therapeutic development.

His expertise extends beyond academia, as he has served as a consultant for several major pharmaceutical companies, including Novartis, Ionis, and Merck. Dr. Rivella has also played a critical role in designing clinical trials and analyzing data for various drugs, contributing to the advancement of gene therapy and hematology on a global scale.

🏆 Accolades and Recognition :

Dr. Rivella’s contributions to the field have been widely recognized through numerous awards and honors. Early in his career, he received multiple Travel Grant Awards from prestigious organizations such as the International Society of Experimental Hematology (ISEH) and the American Society of Gene & Cell Therapy (ASGCT). Notably, in 2015, he was honored with the Sultan bin Khalifa International Thalassemia Federation Award for Innovative Medical Research, highlighting his impact on thalassemia treatment.

In 2019, Dr. Rivella was awarded the Marcel Simon Award by the International BioIron Society (IBIS), further cementing his status as a leader in the field of iron metabolism and hematology. His most recent accolade, the Outstanding Poster Award in 2024 for his work on lentiviral gene therapy, underscores his ongoing contributions to cutting-edge research in gene therapy.

🌍 Impact and Influence :

Dr. Rivella’s influence extends beyond his immediate research contributions. As a member and leader of various scientific societies, including the American Society of Hematology (ASH) and the International BioIron Society (IBIS), he has helped shape the direction of research and clinical practice in hematology and gene therapy. His role on the Scientific Advisory Boards (SAB) of several biopharmaceutical companies allows him to directly impact the development of new therapies, ensuring that innovative treatments reach patients.

🏅 Legacy and Future Contributions :

Dr. Rivella’s legacy in pediatric hematology and gene therapy is profound. Through his work, countless patients with hemoglobinopathies and other genetic disorders have new hope for effective treatments. His pioneering efforts in RNA gene therapeutics promise to revolutionize the field, offering novel approaches to previously intractable conditions.

As he continues his research and leadership at CHOP and The Penn Institute for RNA Innovation, Dr. Rivella’s future contributions are poised to further advance the field of gene therapy. His commitment to education, research, and clinical excellence ensures that his legacy will endure, inspiring future generations of scientists and clinicians dedicated to improving the lives of patients with genetic disorders.

🎓Publication 

Iron restriction in sickle cell disease: When less is more

  • Authors   :Oswaldo L. Castro; Lucia De Franceschi; Tomas Ganz; Julie Kanter; Gregory J. Kato; Sant‐Rayn Pasricha; Stefano Rivella; John C. Wood
  • Journal    :American Journal of Hematology
  • Year         :2024

Optimizing lentiviral genomic integrations to cure beta-thalassemia: The least required for success?

    • Authors :Stefano Rivella
    • Journal   :
      Molecular Therapy – Methods & Clinical Development
    • Year       : 2024

Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis

  • Authors  :Raymond Liang; Miao Lin; Vijay Menon; Jiajing Qiu; Anagha Menon; Laura Breda; Tasleem Arif; Stefano Rivella; Saghi Ghaffari
  • Journal    :Blood Advances
  • Year         :  2023.

DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia

  • Authors  :L. K. Metthew Lam; Sophia Murphy; Dimitra Kokkinaki; Alessandro Venosa; Scott Sherrill-Mix; Carla Casu; Stefano Rivella; Aaron Weiner; Jeongho Park; Sunny Shin et al
  • Journal   :
    Science Translational Medicine
  • Year        :   2021

Red Blood Cells Function as DNA Sensors

  • Authors  :Metthew Lam; Sophia Murphy; Dimitra Kokkinaki; Alessandro Venosa; Scott Sherrill-Mix; Carla Casu; Stefano Rivella; Aaron Weiner; Jeongho Park; Sunny Shin et al.
  • Journal   :Preprint
  • Year        :  2021

Mrs. Anke van Engen|Pharmaceutical Policy and Regulation | Best Researcher Award

Mrs. Anke van Engen |Pharmaceutical Policy and Regulation|Best Researcher Award|

Mrs. Anke van Engen atIQVIA,Netherlands

PROFILE  

Scopus

 

Early Academic Pursuits 🎓

Anke van Engen’s academic journey began at the University of Leiden in the Netherlands, where she pursued a Master of Science (MSc) degree in Chemistry, specializing in Bio-organic Chemistry. Her passion for understanding the intricate mechanisms of chemistry and its application to life sciences laid a strong foundation for her future endeavors. Her academic pursuits were not confined to the classroom; she also completed an internship in biochemistry at the Institute of Fundamental Sciences, Massey University in New Zealand, in 1999. This experience provided her with hands-on exposure to research and innovative scientific methodologies, marking the beginning of her profound interest in health economics and outcomes research.

Professional Endeavors 🏢

Anke’s professional journey began in 2000 as a PR Assistant at KPN Research, where she gained experience in communications and public relations within the research and innovation sector. However, her true calling was in consultancy, which she pursued by joining Quintiles Consulting in 2001 as an Associate Consultant. Her initial work focused on health economics (HE) modeling, including decision tree and Markov models, patient chart analyses, and market scans. Anke quickly progressed within the company, taking on roles with increasing responsibility, such as Consultant, Senior Consultant, and eventually Consulting Director.

During her time at Quintiles, Anke developed a unique understanding of innovative technologies for supporting clinical and health outcomes studies. She became instrumental in the development of health economic models used in key submissions to organizations like NICE (National Institute for Health and Care Excellence) and SMC (Scottish Medicines Consortium). Her expertise in market access (MA) strategy, value argument development, and health economics led to her appointment as the Principal at Quintiles Advisory Services, where she led the development of the HTA Accelerator—an online platform that became the flagship product for market access solutions.

In 2017, Anke transitioned to IQVIA, where she continued her trajectory of success. She took on roles such as Senior Principal and Managing Principal, leading international teams and developing EMEA-specific offerings in health economics and market access. Her leadership and strategic insights have been crucial in shaping the payer evidence solutions landscape across the EMEA region.

Contributions and Research Focus 🧠

Anke van Engen’s contributions to the field of health economics, outcomes research, and market access are substantial. Her work has focused on developing integrated solutions that provide strategic insights for life sciences companies, enabling them to navigate the complex landscape of health technology assessments (HTAs) and market access requirements. Her leadership in the development of the HTA Accelerator platform has been particularly impactful, offering a comprehensive solution for gathering payer insights and facilitating launch readiness.

Anke’s research focus extends beyond practical applications to thought leadership in the industry. She has consistently contributed to the development of innovative methodologies and best practices in health economics and market access, helping to advance the field and improve the commercial success of pharmaceutical products.

Accolades and Recognition 🏆

Throughout her career, Anke has received numerous awards and accolades that reflect her expertise and influence in the field. Notable among these are the ISPOR Best Podium and Poster Awards, which she received in 2012 and 2011, respectively, for her work on understanding the complexities of HTA networks and the stakeholder decision-making process in the UK. Her contributions have been recognized at various international conferences, where her issue panels have consistently ranked among the top-attended sessions. In 2014, she won the Sharktank contest for best innovation, securing investment for the HTA Accelerator platform—a testament to her innovative thinking and ability to drive impactful solutions.

Impact and Influence 🌍

Anke van Engen is widely respected by her colleagues, clients, and the broader industry for her deep expertise, strategic vision, and collaborative approach. Her ability to build long-lasting partnerships with clients and deliver consistent results has made her a trusted advisor in the life sciences sector. She has played a pivotal role in shaping the market access landscape in Europe and beyond, influencing the way companies approach payer evidence strategies.

🎓Publication 

Use of External Comparators for Health Technology Assessment Submissions Based on Single-Arm Trials

  • Authors   :Patel, D., Grimson, F., Mihaylova, E., van Engen, A., Kim, J
  • Journal    :Value in Health
  • Year         :2021

 

Prof Dr. THAWATCHAI PHAECHAMUD| Drug Delivery Systems | Best Researcher Award-1299

Prof Dr. THAWATCHAI PHAECHAMUD, Drug Delivery Systems ,Best Researcher Award

Prof Dr. THAWATCHAI PHAECHAMUD atSilpakorn University,Thailand

PROFILE  

Google scholar 

Scopus

Orcid

Early Academic Pursuits 🎓

Thawatchai Phaechamud, Mr., embarked on his academic journey at the Faculty of Pharmacy, Silpakorn University, Thailand, where he earned his Bachelor of Pharmacy (B.Pharm) degree in 1991. Demonstrating a strong interest in pharmaceutical sciences from an early stage, he advanced his studies at the Faculty of Pharmaceutical Sciences, Chulalongkorn University. There, he completed his Master of Science (M.Sc.) in Manufacturing Pharmacy in 1995, with a thesis focused on the “Effect of variables in chitosan film on propranolol hydrochloride coated tablets.” His academic journey culminated in a Ph.D. in Pharmaceutics from the same institution in 1999. His doctoral thesis, titled “Film-coating of chitosan onto propranolol hydrochloride tablet: Approach to fast and extended drug release,” laid the foundation for his future contributions to the field of pharmaceutics, particularly in drug delivery systems.

Professional Endeavors 🧑‍🏫

Mr. Phaechamud began his professional career as a Lecturer at the Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, from 1991 to 1993. During this period, he honed his teaching skills and laid the groundwork for a lifelong commitment to academia. From 1994 to 1996, he served as a research student at the Faculty of Pharmaceutical Sciences, Chulalongkorn University, further deepening his research capabilities. His academic prowess earned him a position as a Visiting Scientist at the Department of Pharmaceutics, Toyama Medical & Pharmaceutical University in Japan from November 1997 to January 1998.

Upon completing his Ph.D., Mr. Phaechamud returned to Silpakorn University, where he served as an Assistant Professor from 1999 to 2003 in the Department of Pharmaceutical Technology. His dedication to teaching and research led to his promotion to Associate Professor in 2004, a position he has held ever since. His roles have expanded over the years, including serving as the Head of the Department of Pharmaceutical Technology from 2008 to 2009 and Chairman of the Pharmaceutical Engineering Doctoral Program from 2017 to 2018. Since 2018, Mr. Phaechamud has held the esteemed title of Professor in the Department of Industrial Pharmacy, Faculty of Pharmacy at Silpakorn University.

Contributions and Research Focus 🔬

Mr. Phaechamud’s research interests are diverse, focusing on various aspects of pharmaceutical sciences. His work primarily revolves around controlled drug delivery systems, in situ forming gels, matrix film and tablet characterizations, herbal preparation and development, pharmaceutical film coating, and pharmaceutical excipient characterization. He has made significant contributions to the development of controlled drug delivery systems, a field that aims to enhance the efficacy and safety of medications by controlling the rate, time, and place of drug release.

His expertise in polymeric film characterization and pharmaceutical excipient characterization has been instrumental in advancing the understanding of drug delivery mechanisms. His work on in situ forming gels and matrix films has paved the way for innovative drug delivery solutions, particularly in the treatment of chronic conditions where sustained drug release is crucial.

Accolades and Recognition 🏆

Throughout his illustrious career, Mr. Phaechamud has received numerous accolades and recognition for his contributions to pharmaceutical sciences. In June 2006, he was honored as a TRF Research Scholar by The Thailand Research Fund, a prestigious recognition of his research excellence. His leadership in the “Development of standard extract of SC for pharmaceutical and cosmetic applications” research program at Silpakorn University in 2008-2009 further solidified his reputation as a leading researcher in his field.

His publications in high-impact journals reflect the quality and impact of his research. Notable publications include works in the International Journal of Biological Macromolecules, Polymers, AAPS PharmSciTech, and Pharmaceutics, where his research on topics such as transdermal and periodontal pocket drug delivery systems, in situ gels, and solvent-removal zein-based in situ gels has garnered significant attention.

Impact and Influence 🌍

Mr. Phaechamud’s research has had a profound impact on the field of pharmaceutics, particularly in the area of drug delivery systems. His work on controlled drug delivery systems and in situ forming gels has influenced the development of new therapeutic approaches that improve patient outcomes by ensuring more effective and targeted drug delivery.

His influence extends beyond research; as an educator, he has mentored countless students, many of whom have gone on to become leaders in the pharmaceutical industry and academia. His teachings on modified release solid dosage forms, controlled drug delivery systems, and polymer degradation have been instrumental in shaping the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🌟

Mr. Phaechamud’s legacy is one of innovation, dedication, and excellence in the field of pharmaceutical sciences. His work has not only advanced the understanding of drug delivery mechanisms but also paved the way for new therapeutic solutions that have the potential to improve the lives of millions of patients worldwide.

As he continues his work at Silpakorn University, Mr. Phaechamud is

🎓Publication 

Moist heat treatment on physicochemical change of chitosan salt films

  • Authors   :Garnpimol C Ritthidej, Thawatchai Phaechamud, Tamotsu Koizumi
  • Journal    :International journal of pharmaceutics
  • Year         :2002

Gentamicin sulfate-loaded porous natural rubber films for wound dressing

    • Authors :Thawatchai Phaechamud, Pongsathorn Issarayungyuen, Wiwat Pichayakorn
    • Journal   :International journal of biological macromolecules
    • Year       : 2016

Sustained-release from layered matrix system comprising chitosan and xanthan gum

  • Authors  :Thawatchai Phaechamud, Garnpimol C Ritthidej
  • Journal    :Drug development and industrial pharmacy
  • Year         :  2007

The study of antioxidant capacity in various parts of Areca catechu L.

  • Authors  :Penpun Wetwitayaklung, Thawatchai Phaechamud, Chutima Limmatvapirat, Sindhchai Keokitichai
  • Journal   :Naresuan University Journal: Science and Technology (NUJST)
  • Year        :   2006

Antibacterial activity and drug release of chitosan sponge containing doxycycline hyclate

  • Authors  :Thawatchai Phaechamud, Juree Charoenteeraboon
  • Journal   :Aaps PharmSciTech
  • Year        :  2008

Assoc Prof Dr. Nitesh Poddar| Protein Biochemistry | Excellence in Innovation Awards

Assoc Prof Dr. Nitesh Poddar, Protein Biochemistry ,Excellence in Innovation Awards

Assoc Prof Dr. Nitesh Podda at Manipal University – Jaipur Campus,India

PROFILE  

Google scholar 

 

Early Academic Pursuits 🎓

Dr. Nitesh Kumar Poddar began his academic journey with a strong foundation in the life sciences. He completed his M.Sc. in Biotechnology from the esteemed Jamia Millia Islamia, New Delhi, in 2001. This academic achievement was followed by a Ph.D. from the same institution in 2004, where he worked under the supervision of Prof. Faizan Ahmad, an INSA Senior Scientist. Dr. Poddar’s doctoral research focused on the “Effects of Size of Polyols on the Protein Folding/Unfolding Equilibrium under Physiological Conditions.” His research shed light on the role of osmolytes, particularly sugars, in stabilizing proteins, an essential aspect of protein chemistry. This early work laid the foundation for his future research in protein folding, stability, and aggregation.

Professional Endeavors 🧑‍🔬

Dr. Poddar’s professional journey is marked by significant contributions in academia and research. He is currently an Associate Professor in the Department of Biosciences at Manipal University, Jaipur, a position he has held since February 15, 2019. Before this, he served as an Associate Professor in the Department of Biotechnology at Invertis University, Bareilly, from September 2017 to February 2019. He also worked as an Assistant Professor in the same department from August 2014 to September 2017.

Dr. Poddar’s international experience is noteworthy. He was a Post-Doctoral Research Associate at the University of Toledo, Ohio, USA, from September 2012 to August 2014. Prior to that, he held a similar position at Rice University, Houston, Texas, from October 2009 to September 2012. His postdoctoral research in the United States significantly expanded his expertise in protein folding, DNA dynamics, and the molecular mechanisms underlying neurological disorders.

In addition to his academic roles, Dr. Poddar gained valuable industrial experience as a Visiting Research Fellow at Yashraj Biotechnology Ltd., Mumbai, from July 2004 to June 2005. This experience provided him with practical insights into the application of biotechnological research in industry, further enriching his academic and research portfolio.

Contributions and Research Focus 🔬

Dr. Poddar’s research interests are centered around protein folding, misfolding diseases, bio-nanotechnology, and the development of therapeutic strategies. His major contributions include:

  • Protein Folding and Stability: Dr. Poddar has extensively studied the folding and stability of proteins, particularly the role of osmolytes in these processes. His research has provided valuable insights into the mechanisms that govern protein folding and the factors that can lead to protein aggregation, a hallmark of several neurodegenerative diseases.
  • Neurodegenerative Diseases: He has explored the role of mTOR in Alzheimer’s disease and various types of cancer, with a particular focus on prostate cancer. His work in this area has contributed to a better understanding of the molecular pathways involved in these diseases, potentially leading to new therapeutic approaches.
  • Nanotechnology in Protein Folding: Dr. Poddar has investigated the application of nano-osmolytes and nanoparticles in protein folding and aggregation. His research in this area aims to develop novel strategies to prevent or reverse protein misfolding, which is crucial in the context of neurodegenerative diseases.
  • Microbial Fuel Cells: He has also contributed to the development of microbial fuel cells (MFCs) for the effective desalination of environmental biopollutants. This work highlights his commitment to applying biotechnological solutions to environmental challenges.
  • COVID-19 Research: During the COVID-19 pandemic, Dr. Poddar explored the relationship between infectious and non-infectious diseases and therapeutic strategies through natural-based products. His research in this area has been timely and relevant, addressing urgent global health challenges.

Accolades and Recognition 🏅

Dr. Poddar’s expertise and contributions have been recognized through various editorial roles and memberships in professional bodies. He is the Lead Editor of a special issue on “Cytokine Storm and Amyloid Pathology Including Viral Infection in Neurological Infections” for Hindawi Journal, a Scopus Indexed publication. Additionally, he served as an Editor for a special issue in the “Biocatalysis and Agricultural Biotechnology (BCAB) Journal” focused on the implementation of phytochemistry and nanotechnology in managing health issues, including COVID-19.

Dr. Poddar is also an Associate Editorial Board Member of “Current Biotechnology” by Bentham Science Publisher. These editorial roles reflect his standing in the scientific community and his contributions to advancing knowledge in his fields of expertise.

Impact and Influence 🌍

Dr. Poddar’s work has had a significant impact on the fields of protein chemistry, neurodegenerative diseases, and bio-nanotechnology. His research on protein folding and misfolding has enhanced the understanding of these processes at a molecular level, contributing to the development of new therapeutic strategies for diseases such as Alzheimer’s and cancer. His interdisciplinary approach, combining biotechnology with nanotechnology, has opened new avenues for research and innovation.

Legacy and Future Contributions 🌟

As an educator, researcher, and editor, Dr. Poddar’s legacy is one of dedication to advancing scientific knowledge and mentoring the next generation of scientists. His work in protein folding, neurodegenerative diseases, and nanotechnology will continue to influence these fields for years to come. Looking to the future, Dr. Poddar is poised to make further contributions to biotechnology and its applications in health and environmental sciences. His ongoing research and editorial work will likely lead to new discoveries and innovations, solidifying his legacy as a leader in his field.

🎓Publication 

Protein and DNA destabilization by osmolytes: the other side of the coin

  • Authors   :Laishram R Singh, Nitesh Kumar Poddar, Tanveer Ali Dar, Raj Kumar, Faizan Ahmad
  • Journal    :Life sciences
  • Year         :2011

Saponins: Extraction, bio-medicinal properties and way forward to anti-viral representatives

    • Authors :Pallavi Sharma, Arti Tyagi, Pravin Bhansali, Shubhra Pareek, Vineeta Singh, Ashal Ilyas, Rajeev Mishra, Nitesh Kumar Poddar
    • Journal   :Food and Chemical Toxicology
    • Year       : 2021

Effect of monomeric and oligomeric sugar osmolytes on ΔGD, the Gibbs energy of stabilization of the protein at different pH values: Is the sum effect of monosaccharide …

  • Authors  :Nitesh Kumar Poddar, ZA Ansari, RK Brojen Singh, AA Moosavi-Movahedi, Faizan Ahmad
  • Journal    :Biophysical Chemistry
  • Year         :  2008

Tau and mTOR: The hotspots for multifarious diseases in Alzheimer’s development

  • Authors  :NITESH KUMAR PODDAR, Zeba Mueed, Pallavi Tandon, Sanjeev Maurya, Ravi Deval, Mohammad Amjad Kamal
  • Journal   :Frontiers in neuroscience
  • Year        :   2019

Forty years of research on osmolyte-induced protein folding and stability

  • Authors  :LR Singh, NK Poddar, TA Dar, S Rahman, R Kumar, F Ahmad
  • Journal   :Journal of the Iranian Chemical Society
  • Year        :  2011

Prof.Aleksandr Urakov|Drug Repurposing | Best Researcher Award

Prof.Aleksandr Urakov, Drug Repurposing ,Best Researcher Award

Prof.Aleksandr Urakov atIzhevsk State Medical Academy,Russia

PROFILE  

scopus

Orcid

Academic Leadership 🏫

Professor Aleksandr Urakov serves as the head of the Department of General and Clinical Pharmacology at Izhevsk State Medical Academy. His leadership has been instrumental in shaping the department into a center of excellence in pharmacological research and education.

Innovative Contributions 🧠

As an inventor, Professor Urakov holds over 270 patents and has published more than 200 scientific articles . His research in temperature pharmacology and drug repurposing  has led to significant advancements, including the development of the floating tablet and warm alkaline hydrogen peroxide solutions .

Recognition and Honors 🎖️

For his remarkable contributions, Professor Urakov has been awarded the Order of the Badge of Honor and holds the prestigious title of Honored Inventor of the Russian Federation . His work continues to influence and inspire the medical community globally.

Research and Innovations🔬 :

Professor Urakov invented the floating tablet and discovered warm alkaline hydrogen peroxide solutions (WAHPSs), which include new drug subgroups like bruise bleaches, pus-dissolving drugs (pyolytics), and oxygen-producing antihypoxants. These innovations offer alternatives to ECMO for hypoxemia in COVID-19 asphyxia.

🎓Publication 

Comment: Balanced Salt Solutions for Critically Ill Patients: Nonplused and Back to Basics

Thermal imaging of local skin temperature as part of quality and safety assessment of injectable drugs

    • Authors :Urakov, A., Urakova, N., Samorodov, A., Suntsova, D., Muhutdinov, N..
    • Journal   :Heliyon
    • Year       : 2024

Understanding burn injuries in children – A step toward prevention and prompt first aid

  • Authors  :Urakov, A.L., Suntsova, D.O., Yagudin, I.I.
  • Journal    :Burns
  • Year         :  2023

ASSESSMENT OF FETAL RESISTANCE TO HYPOXIA USING THE STANGE TEST AS AN ADJUNCT TO APGAR SCALE ASSESSMENT OF NEONATAL HEALTH STATUS

  • Authors  :Shabanov, P.D., Urakov, A.L., Urakova, N.A.
  • Journal   :Medicinskij Akademiceskij Zurnal,
  • Year        :   2023

Prospects for the pharmacological validation of the use of platelets as a “peripheral model” of neurons

Assoc Prof Dr.Guanyu Chen|Drug Delivery Systems | Best Researcher Award

Assoc Prof Dr.Guanyu Chen, Drug Delivery Systems,Best Researcher Award

Assoc Prof Dr.Guanyu Chen, at Sun Yat-Sen University School of Pharmaceutical Sciences Shenzhen,China

PROFILE  

scopus

🧪 Research Focus :

Associate Prof. Guanyu Chen is an expert in Drug Delivery and Immunochemotherapy at the School of Pharmaceutical Sciences, Sun Yat-sen University.

🎓 Education and Professional Experience :

He earned his Bachelor’s (2005-2008), Master’s (2009-2012), and PhD (2012-2016) degrees from the University of Auckland, New Zealand. Following his PhD, he worked as a Postdoctoral Fellow at the same university from 2017 to 2019. During this time, he also served as a Research Assistant at Ancare Scientific Ltd, Douglas Ltd, Alleva Animal Health Ltd, and Kimberly Clack Ltd. In 2019, he joined Sun Yat-sen University, China, as an Associate Professor.

💰 Research Funding :

Prof. Chen has received significant funding for his research, including the National Natural Science Foundation of China in 2022 (82273871), the Guangdong Basic and Applied Basic Research Foundation in 2021 (2021A1515110006), the Shenzhen Science and Technology Program in 2020 (GXWD20201231165807008), the 67th Batch Postdoc Research Foundation of China in 2019 (2020M673030), and the Kimberly Clarks Pharmaceutics Research Fund, USA in 2016 (32715.001).

🏅 Patents and Awards :

His achievements include two national invention patents and several prestigious awards: Overseas Senior Talent of Shenzhen, Recruiting Outstanding Overseas Talent of Guangdong, Maurice and Phyllis Paykel Research Award, Academic Career Exploration Scholarship, Edna and Denis Moloney Scholarship, FMHS-PGSA Award from the University of Auckland, Elite Editing Thesis Write-up Scholarship from Australia, and The University of Auckland Partnership Appeal Award.

📚 Editorial Roles :

Prof. Chen contributes to the academic community as a Youth Editorial Board Member for Acta Materia Medica and the Journal of Drug Delivery and Translational Research. He also serves as a Guest Editor for the Journal of Current Drug Delivery and Pharmaceutics.

🔍 Conclusion

Associate Prof. Guanyu Chen stands out as a leading researcher in drug delivery and immunochemotherapy, with a robust academic background and extensive experience. His significant contributions to the field are supported by notable research funding and a series of prestigious awards. As a dedicated academic and editorial contributor, Prof. Chen continues to advance pharmaceutical sciences through his research, mentorship, and publication efforts.

🎓Publication 

The scaffold protein AXIN1: gene ontology, signal network, and physiological function

Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis

Cryo-Milled β-Glucan Nanoparticles for Oral Drug Delivery

  • Authors  :Chen, G., Liu, Y., Svirskis, D., Lu, W., Wen, J.
  • Journal    :Pharmaceutics
  • Year         :  2024

Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy

Development of a novel peptide targeting GPR81 to suppress adipocyte-mediated tumor progression

  • Authors  :Chen, S., Zhou, X., Li, W., Liu, J., Gao, Y.
  • Journal   :Biochemical Pharmacology
  • Year        :  2023

Prof. Mohamed Abdelzaher|Pharmacology | Best Researcher Award

Prof. Mohamed Abdelzaher, Pharmacology,Best Researcher Award

Prof. Mohamed Abdelzaher, at Environmental Science and Industrial Development Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University,Egypt

PROFILE

scopus

Early Academic Pursuits 🎓

Mohamed Abuelseoud Abdelzaher embarked on his academic journey at Minia University, where he pursued a Bachelor of Science degree at the Faculty of Science. His passion for environmental science led him to further his studies, culminating in an MSc in Environmental Chemistry from the same institution. His master’s thesis focused on the physico-chemical properties of sewage sludge ash blended cement pastes, a topic that underscored his growing interest in sustainable construction materials. His academic pursuits did not stop there, as he later achieved a Ph.D. in Environmental Science and Industrial Development from the Faculty of Postgraduate Studies for Advanced Sciences at Beni-Suef University in 2019. His doctoral research delved into enhancing the physico-mechanical properties of white cement through the application of nanoparticles, highlighting his commitment to advancing materials science and its environmental implications.

Professional Endeavors 🏢

Dr. Abdelzaher’s professional career began in the industrial sector, where he worked as a Quality Control and Labs Manager at Italcementi Group, Helwan Cement Co., from 2005 to 2017. This role allowed him to gain substantial experience in quality assurance and environmental management within the cement industry. His work in this capacity was instrumental in ensuring that the company adhered to stringent environmental and quality standards, contributing to the sustainability of its operations.

In 2017, Dr. Abdelzaher transitioned into academia, taking on the role of Assistant Professor of Environmental Science and Industrial Development at Beni-Suef University’s Faculty of Postgraduate Studies for Advanced Sciences. In this role, he has been actively involved in teaching, research, and mentorship, guiding the next generation of environmental scientists and engineers. His professional journey reflects a seamless blend of industry experience and academic expertise, making him a respected figure in both fields.

Contributions and Research Focus 🔬

Dr. Abdelzaher’s research is primarily centered on the application of nanomaterials in construction materials and environmental science, with a particular emphasis on waste management. His work on enhancing the properties of white cement using nanoparticles is a testament to his innovative approach to solving environmental and industrial challenges. By integrating cutting-edge nanotechnology into traditional construction materials, he has contributed to the development of more durable and sustainable building solutions.

In addition to his research in construction materials, Dr. Abdelzaher has also made significant contributions to environmental science, particularly in the area of waste management. His work explores how waste materials can be repurposed and utilized in environmentally friendly ways, thereby reducing their impact on the environment and contributing to a circular economy.

Accolades and Recognition 🏅

Throughout his career, Dr. Abdelzaher has received numerous accolades and certifications that attest to his expertise and leadership in his field. He is a certified environmental specialist, having received recognition from the Egyptian Ministry of Environment. He also holds an MBA from Ain Shams University, which complements his scientific expertise with strong business acumen.

Dr. Abdelzaher’s leadership skills have been recognized on an international level, as evidenced by his fellowship from the Science Leadership Program in Africa. This fellowship highlights his role as a thought leader in environmental science, particularly in the context of developing nations. Additionally, he has been awarded fellowships for curriculum development and environmental management, further underscoring his contributions to academia and industry alike.

Impact and Influence 🌍

Dr. Abdelzaher’s work has had a profound impact on both the academic community and the industrial sector. His research on nanomaterials and waste management has influenced the development of more sustainable construction practices, contributing to the global push towards greener building solutions. His teachings and mentorship at Beni-Suef University have inspired countless students to pursue careers in environmental science, ensuring that his influence will be felt for generations to come.

Moreover, his involvement in various professional organizations and his role as a reviewer for environmental journals published by Elsevier demonstrate his commitment to advancing the field of environmental science. Through these roles, he has helped shape the direction of research and development in his field, ensuring that it continues to address the most pressing environmental challenges of our time.

Legacy and Future Contributions 🚀

As Dr. Abdelzaher continues his career, his legacy is one of innovation, leadership, and dedication to sustainability. His work in nanotechnology and waste management has laid the groundwork for future advancements in these fields, and his influence as an educator ensures that his knowledge and expertise will be passed on to the next generation of environmental scientists.

🎓Publication 

Effective impact of nano-plastic-waste incorporated with nanotitina on the physical, mechanical and microstructural properties of white cement pastes composites for progressing towards sustainability

  • Authors   :Abdelzaher, M.A., Farghali, A.A., Hamouda, A.S.
  • Journal    :Scientific Reports
  • Year         :2024

Production, characterization and performance of green geopolymer modified with industrial by-products

    • Authors :Abbas, R., Abdelzaher, M.A., Shehata, N., Tantawy, M.A.
    • Journal   :Scientific Report
    • Year       : 2024

Effect of ginger, chamomile, and green tea extracts on prostate cancer cells

Bacterial biodegradation of oil-contaminated soil for pollutant abatement contributing to achieve sustainable development goals: A comprehensive review

  • Authors  :Aziz, Z.S., Jazza, S.H., Dageem, H.N., Balboul, B.A., Abdelzaher, M.A.
  • Journal   :Results in Engineering
  • Year        :   2024

Experimental and Theoretical Study of Water Amount on the Rheological Features of Marble Sludge Grout

Assist Prof Dr. Tewin Tencomnao| Herbal Medicine|Best Researcher Award

Assist Prof Dr. Tewin Tencomnao, Herbal Medicine,Best Researcher Award

Assist Prof Dr. Tewin Tencomnao, at Chulalongkorn University,Thailand

PROFIL

Google scholar 

🎓Early Academic Pursuits :

Asst. Prof. Dr. Tewin Tencomnao’s academic journey began with a strong foundation in medical technology. He earned his Bachelor of Science (B.S.) degree in Medical Technology with honors in 1994 from Chulalongkorn University, Bangkok, Thailand. This early achievement was a precursor to his dedication to academic excellence and set the stage for his future endeavors in biochemistry and molecular biophysics. Driven by a passion for scientific inquiry, Dr. Tencomnao pursued further education abroad, obtaining his Ph.D. in Biochemistry and Molecular Biophysics in 2001 from the prestigious Medical College of Virginia Campus of Virginia Commonwealth University in Richmond, Virginia, USA.

His pursuit of knowledge didn’t stop there. After earning his Ph.D., Dr. Tencomnao embarked on postdoctoral research training at the Institute of Molecular Medicine and Genetics, Medical College of Georgia, Georgia Health Sciences University, Augusta, Georgia, USA, from 2001 to 2002. This period of intensive research provided him with advanced skills and deepened his understanding of molecular biology and genetics, which would become central themes in his later work.

🧪Professional Endeavors :

Dr. Tewin Tencomnao’s professional career is marked by a series of prestigious appointments that reflect his expertise and leadership in the field of biochemistry and molecular biology. He currently holds several key positions at Chulalongkorn University, one of Thailand’s leading educational institutions. As the Head of the Center of Excellence on Natural Products for Neuroprotection and Anti-Ageing, Dr. Tencomnao leads cutting-edge research initiatives aimed at discovering natural products with neuroprotective and anti-aging properties. This role underscores his commitment to addressing some of the most pressing health challenges of our time, including neurodegenerative diseases and the aging process.

Dr. Tencomnao also chairs the Bachelor’s Degree Program in Medical Technology at the Faculty of Allied Health Sciences. In this capacity, he oversees the curriculum and ensures that the program remains at the forefront of medical technology education. His leadership in this role has helped maintain the program’s reputation for excellence, producing graduates who are well-prepared to meet the demands of the healthcare industry.

🔬Contributions and Research Focus :

Dr. Tencomnao’s research interests are broad and multidisciplinary, encompassing drug discovery, natural products, molecular biology, biochemistry, and neuroscience. His work is particularly focused on understanding the mechanisms underlying neuropsychiatric diseases, anti-aging, and neuroprotection. Through his research, Dr. Tencomnao aims to uncover new therapeutic strategies that can improve the quality of life for individuals suffering from neurodegenerative diseases and age-related conditions.

🏆Accolades and Recognition :

Dr. Tencomnao’s contributions to science and education have not gone unnoticed. In 2021, he was awarded a Fulbright grant as a Thai Visiting Scholar to conduct research in the USA. This prestigious grant allowed him to further his research at the Department of Physiology, College of Medicine, University of Kentucky. The Fulbright award is a testament to Dr. Tencomnao’s international reputation as a leading researcher in his field.

In 2015, Dr. Tencomnao was honored with the DMSc Award from the Department of Medical Sciences, Ministry of Public Health, Thailand, for his outstanding research on the anti-neuroprotective effects and mechanisms of Rhinacanthus nasutus extracts. His innovative research was also recognized internationally when he received the Gold Award in the field of innovation from Universiti Malaysia Perlis, Malaysia, at the International Engineering Invention & Innovation Exhibition (i-ENVEX) for his work on an anti-aging cream with natural resveratrol from Perlis grapevine.

🌍Impact and Influence :

Dr. Tencomnao’s impact extends beyond his research contributions. As an educator, he has influenced countless students who have gone on to make their mark in various fields of science and healthcare. His work at Chulalongkorn University has helped shape the direction of research and education in Thailand, particularly in the areas of biochemistry, molecular biology, and natural products.

His research on neuroprotection and anti-aging has the potential to impact public health on a global scale. By identifying natural compounds that can protect against neurodegeneration, Dr. Tencomnao’s work could lead to the development of new treatments for some of the most challenging diseases of our time. His research also contributes to the growing body of knowledge on the health benefits of natural products, which is increasingly important as the world seeks sustainable and natural solutions to health challenges.

🌟Legacy and Future Contributions :

Asst. Prof. Dr. Tewin Tencomnao’s legacy is one of innovation, leadership, and a commitment to advancing science and education. His work in neuroprotection, anti-aging, and natural products has already made a significant impact, and his ongoing research promises to continue this trend. As he continues to lead the Center of Excellence on Natural Products for Neuroprotection and Anti-Ageing, his future contributions will likely further our understanding of how natural products can be used to promote health and longevity.

🎓Publication 

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

  • Authors   :Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, Mahmoud Abdellatif, Asghar
  • Journal    :autophagy
  • Year         :2021

A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy

    • Authors :Mani Iyer Prasanth, Bhagavathi Sundaram Sivamaruthi, Chaiyavat Chaiyasut, Tewin Tencomnao
    • Journal   :Nutrients
    • Year       : 2019

Amyloidosis in Alzheimer’s Disease: The Toxicity of Amyloid Beta (Aβ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy

  • Authors  :Anchalee Prasansuklab, Tewin Tencomnao
  • Journal    :Evidence‐Based Complementary and Alternative Medicine
  • Year         :  2013

Effects of Thai medicinal herb extracts with anti-psoriatic activity on the expression on NF-κB signaling biomarkers in HaCaT keratinocytes

  • Authors  :Chanachai Saelee, Visa Thongrakard, Tewin Tencomnao
  • Journal    :Molecules
  • Year         :  2011

Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach

  • Authors  :Panthakarn Rangsinth, Chanin Sillapachaiyaporn, Sunita Nilkhet, Tewin Tencomnao, Alison T Ung, Siriporn Chuchawankul
  • Journal    :Journal of traditional and complementary medicine
  • Year         :  2021

Dr. David Chukwu Obas| Medical Biochemistry and Toxicology|Outstanding Scientist Award

Dr. David Chukwu Obas, Medical Biochemistry and Toxicology,Outstanding Scientist Award

Dr. David Chukwu Obas, at International Institute for Toxicology,Nigeria

PROFILE

scopus
Orcid

🎓Early Academic Pursuits :

Dr. David Chukwu Obasi was born on May 10, 1985, in Abakaliki, Ebonyi State, Nigeria. His academic journey began at Umuka Community Primary School in Okposi, where he laid the foundation for his educational aspirations. He continued his studies at Government Secondary School Okposi, where he completed his West African School Certificate (WASC) in 2002. Dr. Obasi pursued a Bachelor of Science degree in Biochemistry at Anambra State University, graduating in 2009. His quest for knowledge propelled him further into academia, where he earned a Master of Science in Medical Biochemistry from Ebonyi State University in 2015. His dedication culminated in a Ph.D. in Medical Biochemistry from the University of Nigeria, Nsukka, in 2020. Throughout these formative years, Dr. Obasi developed a robust understanding of biochemistry, preparing him for his future endeavors in research and academia.

💼Professional Endeavors :

Dr. Obasi’s professional journey is marked by a series of significant academic positions, reflecting his expertise in medical biochemistry. He began his career as a Graduate Assistant at Evangel University, Akaeze, Ebonyi State, where he honed his teaching skills from 2012 to 2015. His dedication and academic prowess led to progressive promotions, first to Assistant Lecturer, then Lecturer II, and subsequently Lecturer I at Evangel University until 2022. In 2022, he took on the role of Senior Lecturer at David Umahi Federal University of Health Sciences in Uburu, Ebonyi State. Dr. Obasi’s academic leadership has been recognized through his appointment as the Acting Head of the Medical Biochemistry Department, where he influences the curriculum and research initiatives.

🔬Contributions and Research Focus :

Dr. Obasi’s research primarily focuses on the biochemical aspects of health and disease, with a special emphasis on toxicity and antioxidant effects of various substances. His contributions to the field are exemplified by his presentations at prestigious conferences, where he shared groundbreaking findings. Notable among these was his paper on the toxicity of aqueous stem-bark extract of Albizia chevalieri on juvenile African catfish, presented at the 13th South East Zonal Conference of the Nigerian Society of Biochemistry and Molecular Biology. He has also explored the bioactive constituents and antioxidant properties of herbal remedies, reflecting a commitment to understanding natural compounds’ roles in health.

His ability to review scholarly articles for reputable journals, such as the Nigerian Journal of Biochemistry and Molecular Biology and Scientific African, further underscores his dedication to advancing scientific knowledge.

🏆Accolades and Recognition :

Throughout his career, Dr. Obasi has received various accolades for his contributions to the field of medical biochemistry. His research and presentations at national conferences have garnered attention, enhancing his reputation among peers and establishing him as a thought leader in his area of expertise. The recognition he has received not only highlights his academic achievements but also his role in advancing the field of biochemistry in Nigeria.

🌍Impact and Influence :

Dr. Obasi’s influence extends beyond his research and teaching. As a dedicated educator, he plays a pivotal role in shaping the next generation of biochemists. His responsibilities include advising students, supervising seminars and projects, and fostering an environment of inquiry and innovation. His leadership roles, including his position as the Acting Head of the Medical Biochemistry Department, allow him to impact curriculum development and departmental strategies. Furthermore, his active membership in professional organizations like the Nigerian Society of Biochemistry and Molecular Biology and the Society of Toxicology showcases his commitment to collaboration and professional development within the scientific community.

🔮Legacy and Future Contributions :

Dr. David C. Obasi’s legacy is characterized by his contributions to medical biochemistry and his role as a mentor and leader in academia. His commitment to research and teaching has laid a foundation for future generations of biochemists. As he continues to explore the biochemical implications of natural products and their potential therapeutic effects, Dr. Obasi aims to contribute significantly to the scientific community. His vision for future research includes exploring innovative solutions to health challenges faced by his community and beyond. Through ongoing collaboration with fellow researchers and institutions, he aspires to further elevate the standards of biochemistry education and research in Nigeria.

🎓Publication 

Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine

  • Authors   :Egwu, C.O., Aloke, C., Onwe, K.T., Obasi, D.C., Okoro, C.O.
  • Journal    :Molecules
  • Year         :2024

Effect of Ruzu Herbal Bitters on the Liver Function and Lipid Profile Parameters of Alloxan-Induced Diabetic Rats

GC-MS analysis, pH and antioxidant effect of Ruzu herbal bitters on alloxan-induced diabetic rats